Alcohol and withdrawal: From animal research to clinical issues

Neuroscience and Biobehavioral Reviews

Volumn 27, Issue 3, 2003, Pages 189-197

  De Witte, Ph ^a   Pinto, E ^b   Ansseau, M ^b   Verbanck, P ^c  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Alcohol; Amino Acids; Dopamine; Noradrenaline; Serotonin; Stress; Withdrawal

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ADENOSINE; ADENOSINE A1 RECEPTOR; ALCOHOL; ALPHA 2 ADRENERGIC RECEPTOR; ASPARTIC ACID; CLONIDINE; DOPAMINE; GLUTAMIC ACID; GROWTH HORMONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; NORADRENALIN; OPIATE RECEPTOR; SEROTONIN; SEROTONIN TRANSPORTER;

ALCOHOL WITHDRAWAL; ALCOHOLISM; ANXIETY; AUTONOMIC NERVOUS SYSTEM FUNCTION; CENTRAL NERVOUS SYSTEM FUNCTION; CEREBROSPINAL FLUID; CORPUS STRIATUM; CORRELATION ANALYSIS; DELIRIUM; DISEASE SEVERITY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; ENDOGENOUS DEPRESSION; HALLUCINATION; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; MENTAL STRESS; MOOD; NEUROMODULATION; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; NUCLEUS ACCUMBENS; OUTCOMES RESEARCH; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REINFORCEMENT; REVIEW; SEIZURE; SEROTONINERGIC SYSTEM; SYMPATHETIC FUNCTION; SYMPTOMATOLOGY; WITHDRAWAL SYNDROME;

ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; ANIMALS; DISEASE MODELS, ANIMAL; ETHANOL; GLUTAMIC ACID; HUMANS; RECEPTORS, N-METHYL-D-ASPARTATE; STRESS; STRESS, PSYCHOLOGICAL; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0038619059     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(03)00030-7     Document Type: Review

References (121)

1. Rossetti Z.L., Carboni S. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur J Pharmacol. 283:1995;177-183.
2. Dahchour A., Quertemont E., De Witte P. Taurine increases in the nucleus accumbens microdialysate after acute ethanol administration to naïve and chronically alcoholised rats. Brain Res. 735:1996;9-19.
3. Dahchour A., De Witte P., Bolo N., Nédélec J.F., Durbin P., Macher J.P. Central effect of acamprosate. Part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate during ethanol withdrawn rats. Psychiat Res Neuroimag. 82:1998;107-114.
4. Tsai G.C., Coyle J.T. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med. 49:1998;173-184.
5. A receptor sub-unit peptide levels in rat cortex during chronic ethanol consumption and withdrawal. J Neurochem. 69:(1):1997;126-130.
6. Dahchour A., De Witte P. Amino acid transmitter systems in substance-related disorders. D'haenen H., den Boer J.A., Westenberg H., Willner P. Textbook of biological psychiatry. 2002;415-424 Wiley, New York.
7. A receptor alpha 4-subunit expression: possible relevance to alcohol dependence. J Neurochem. 68:1997;2485-2492.
8. Samson H.H., Harris R.A. Neurobiology of alcohol abuse. Trends Pharmacol Sci. 13:(5):1992;206-211.
9. Littleton J., Little H. Current concepts of ethanol dependence. Addiction. 89:(11):1994;1397-1412.
10. Jarvis M.F., Becker H.C. Single and repeated episodes of ethanol withdrawal increase adenosine A(1), but not A(2A), receptor density in mouse brain. Brain Res. 786:(1-2):1998;80-88.
11. El Yacoubi M., Ledent C., Parmentier M., Daoust M., Costentin J., Vaugeois J.M. Absence of the adenosine A(2A) receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice. Neuropharmacology. 40:(3):2001;424-432.
12. Gatch M.B., Wallis C.J., Lal H. The effects of adenosine ligands R-PIA and CPT on ethanol withdrawal. Alcohol. 19:(1):1999;9-14.
13. Uzbay I.T., Akarsu E.S., Kayaalp S.O. Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats. Pharmacol Biochem Behav. 49:(4):1994;969-974.
14. Meert T.F., Huysmans H. Repeated characterization of alcohol-withdrawal reactions in rats chronically exposed to an alcohol liquid diet. Progr Neuro-Psychopha. (5):1994;947-960.
15. Weiss F., Parsons L.H., Schulteis G., Hyytiä P., Lorang M.T., Bloom F.E., Koob G.F. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependant rats. J Neurosci. 16:1996;3474-3485.
16. Knutson B., Adams C.M., Fong G.W., Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci. 21:(16):2001;RC159.
17. Imperato A., Dazzi L., Carta G., Colombo G., Biggio G. Rapid increase in basal acetylcholine release in the hippocampus of freely moving rats induced by withdrawal from long-term ethanol intoxication. Brain Res. 784:(1-2):1998;347-350.
18. Rada P., Hoebel B. Aversive hypothalamic stimulation releases acetylcholine in the nucleus accumbens, and stimulation-escape deceases it. Brain Res. 888:2001;60-65.
19. Smolka M., Sanders T., Schmidt L., Samochowiec J., Rommelspacher H., Gscheidel Wendel B., Hoehe M. Mu-opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal. Psychoneuroendocrinology. 24:1999;629-638.
20. Merlo-Pich E., Lorang M., Yeganeh M., Rodriguez De Fonseca F., Raber J., Koob G.F., Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci. 15:1995;5439-5447.
21. Rassnick S., Heinrichs S.G., Britton K.T., Koob G.F. Microinjection of corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 605:(1):1993;25-32.
22. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M., Stalla G.K., Blanquet V., Steckler T., Holsboer F., Wurst W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet. 19:(2):1998;162-166.
23. Adinoff B., Anton R., Linnoila M., Guidotti A., Nemeroff C.B., Bissette G. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence. Neuropsychopharmacology. 15:1996;288-295.
24. Slawecki C.J., Somes C., Ehlers C.L. Effects of chronic ethanol exposure on neurophysiological responses to corticotropin-releasing factor and neuropeptide Y. Alcohol Alcohol. 34:(3):1999;289-299.
25. Roberts A.J., Cole M., Koob G.F. Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol Clin Exp Res. 20:(7):1996;1289-1298.
26. Nutt D. Alcohol and the brain. Pharmacological insights for psychiatrists. Br J Psychiat. 175:1999;114-119.
27. Hall W., Zabor D. The alcohol withdrawal syndrome. Nature. 349:1997;1897-1900.
28. Shiloh R, Nutt D, Weizman A. London: Atlas of Psychiatric Pharmacotherapy. Martin Dunitz; 1999.
29. Wise R.A. The neurobiology of craving: Implications for the understanding and treatment of addiction. J Abnorm Psychol. 97:1988;118-132.
30. Koob G.F., Roberts A.J., Schulteis G., Parsons L.H., Heyser C.J., Hyytiä P., Merlo-Pich E., Weiss F. Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res. 22:1998;3-9.
31. Nestler E.J., Aghajanian J.K. Molecular and cellular basis of addiction. Science. 278:1997;58-63.
32. Schmidt L.G., Dettling M., Graef K.J., Heinz A., Kuhn S., Podschus J., Rommelspacher H. Reduced dopaminergic function in alcoholics is related to severe dependance. Biol Psychiatry. 39:(3):1996;193-198.
33. Noble E.P. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiat. 15:2000;79-89.
34. Roy A., De Jong J., Lamparski D., George T., Linnoila M. Depression among alcoholics. Arch Gen Psychiat. 48:1991;428-432.
35. Jönsson E.G., Nothen M.M., Grunhage F., Farde L., Nakashima Y., Propping P., Sedvall G.C. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiat. 4:1999;290-296.
36. Pohjalainen T., Rinne J.O., Någren K., Lehikoinen P., Anttila K., Syvälahti E., Hietala J. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiat. 3:1998;256-260.
37. Laine T.J., Ahonen A., Räsänen P., Pohjalainen T., Tihonen J., Hietala J. The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics. Alcohol Alcohol. 3:2001;262-265.
38. Laine T.J., Ahonen A., Räsänen P., Tihonen J. Dopamine transporter availability and depressive symptoms during alcohol withdrawal. Psychiat Res-Neuroimag. 90:1999;153-157.
39. Laine T.J., Ahonen A., Torniainen P., Heikkila J., Pyhtinen J., Räsänen P., Niemela O., Hillbom M. Dopamine transporters increase in human brain after alcohol withdrawal. Mol Psychiat. 4:1999;189-191.
40. Sander T., Harms H., Podschus J., Finckh U., Nickel B., Rolfs A., Rommelspacher H., Schmidt L.G. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiat. 41:1997;299-304.
41. Laasonen-Balk T., Kuikka J., Viinamäki H., Husso-Saastamoinen M., Lehtonen J., Tihonen J. Striatal dopamine transporter density in major depression. Psychopharmacology. 144:1999;282-285.
42. Glue P., Nutt D. Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal. Br J Psychiat. 157:1990;491-499.
43. Heinz A., Schmidt K., Sällström-Baum S., Kuhn S., Dufeu P., Schmidt L.G., Rommelspacher H. Influence of dopaminergic transmission on severity of withdrawal syndrome in alcoholism. J Stud Alcohol. 57:1996;471-474.
44. Sano H., Suzuki Y., Ohara K., Yazaki R., Ishigaki T., Yokoyama T., Ohara K. Circadian variation in plasma homovanillic acid level during and after alcohol withdrawal in alcoholic patients. Alcohol Clin Exp Res. 16:1992;1047-1051.
45. Clements J.D. Transmitter timecourse in the synaptic cleft: its role in central synaptic function. Trends Neurosci. 19:1996;163-171.
46. Schmidt L.G., Harms H., Kuhn S., Rommelspacher H., Sander T. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am J Psychiat. 155:1998;474-478.
47. Schmidt L.G., Sander T. Genetics of alcohol withdrawal. Eur Psychiat. 15:2000;135-139.
48. Svensson T.H. Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs. Brain Res Rev. 31:2000;320-329.
49. Parsons L.H., Justice J.J.B. Extracellular concentration and in vivo recovery of DA in the nucleus accumbens using microdialysis. J Neurochem. 58:1992;212-218.
50. Yoshimoto K., McBride W.J. Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat. Neurochem Res. 17:1992;401-407.
51. Imperato A., Di Chiara G. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther. 239:1986;219-228.
52. Ballenger J., Goodwin F., Major L., Brown G. Alcohol and central serotonin metabolism in man. Arch Gen Psychiat. 36:1979;224-227.
53. Mc Bride W.J., Murphy J.M., Yoshimoto K., Lumeng L., Li T.K. Serotonin mechanisms in alcohol drinking behaviors. Drug Dev Res. 30:1993;170-177.
54. Tollefson G.D. Serotonin and alcohol: interrelationships. Psychopathology. 22:(S1):1989;37-48.
55. Heinz A., Ragan P., Jones D.W., Hommer D., Williams W., Knable M.B., Gorey J.G., Doty L., Geyer G., Lee K.S., Coppola R., Weinberger D.R., Linnoila M. Reduced central serotonin transporters in alcoholism. Am J Psychiat. 155:1998;1544-1549.
56. Hammouni S., Payen A., Favre J.D., Balmes J.L., Bénard J.Y., Husson M., Ferrand J.P., Martin J.P., Daoust M. Does the short variant of the serotonin transporter linked polymorphic region constitute a marker for alcohol dependence? Alcohol. 2:1999;107-112.
57. Ciccocioppo R. The role of serotonin in craving: from basic research to human studies. Alcohol Alcohol. 34:1999;244-253.
58. Cloninger C.R. Neurogenetic adaptive mechanisms in alcoholism. Science. 236:1987;410-416.
59. Fils-Aime M.-L., Eckhardt J., George D.T., Brown G.L., Mefford I., Linnoila M. Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxy-indoleacetic acid levels than late-onset alcoholics. Arch Gen Psychiat. 53:1996;211-216.
60. George D.T., Benkelfat C., Rawlings R.R., Eckhardt M.J., Phillips M.J., Nutt D.J., Wynne D., Murphy D.L., Linnoila M. Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in comparison subjects. Am J Psychiat. 154:1997;81-87.
61. Nutt D., Glue P., Molyneux S., Clark C. Alpha-2-adrenoreceptor activity in alcohol withdrawal: a pilot study of the effects of i.v. clonidine in alcoholics and normals. Alcohol Clin Exp Res. 12:1998;14-18.
62. Balldin J., Berggren U., Engel J., Lindstedt G., Sundkler A., Wålinder J. Alpha-2-adrenoreceptor sensitivity in early alcohol withdrawal. Biol Psychiat. 31:1992;712-719.
63. Glue P., Sellman J.D., Nicholls M.G., Abbott R., Joyce P.R., Nutt D. Studies of alpha-2-adrenoreceptor function in abstinent alcoholics. Br J Addict. 84:1989;97-102.
64. Müller N., Hoehe M., Klein H.E., Nieberle G., Kapfhammer H.P., May F., Müller O.A., Fichter M. Endocrinological studies in alcoholics during withdrawal and after abstinence. Psychoneuroendocrinology. 14:1989;113-123.
65. Ansseau M., von Frenckel R., Cerfontaine J.L., Papart P., Franck G., Timsit-Berthier M., et al. Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. Br J Psychiat. 153:1988;65-71.
66. Valdivieso S., Duval F., Mokrani M.C., Schaltenbrand N., Castro J.O., Crocq M.A., Macher J.P. Growth hormone response to clonidine and the cortisol response to dexamethasone in depressive patients. Psychiat Res. 60:1996;23-32.
67. Charney D.S., Heninger G.R. Abnormal regulation of noradrenergic function in panic disorders: effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiat. 43:1986;1052-1054.
68. Uhde T.W., Vittone B.J., Siever L.J., Kaye W.H., Post R.M. Blunted growth hormone response to clonidine in panic disorder patients. Biol Psychiat. 21:1986;1077-1081.
69. Fahlke C., Berggren U., Lundborg C., Balldin J. Psychopathology in alcohol withdrawal: relationship to alpha-2 adrenoreceptor function. Alcohol Alcohol. 5:1999;750-759.
70. Flink E.B. Magnesium deficiency in alcoholism. Alcohol Clin Exp Res. 10:1986;590-594.
71. Bannan L.T., Potter J.F., Beevers D.G., Saunders J.B., Walters J.R., Ingram M.C. Effects of alcohol withdrawal on blood pressure, plasma renin activity, aldosterone, cortisol and dopamine beta-hydroxylase. Clin Sci. 66:1984;659-663.
72. Esel E., Sofuoglu S., Aslan S.S., Kula M., Yabanogly I., Turan M.T. Plasma levels of beta-endorphin, adrenocorticorticotropic hormone and cortisol during early and late alcohol withdrawal. Alcohol Alcohol. 36:2001;572-576.
73. Heinz A., Rommelspacher H., Graf K.J., Kurten I., Otto M., Baumgartner A. Hypothalamic-pituitary-gonadal axis, prolactin, and cortisol in alcoholics during withdrawal and after three weeks of abstinence: comparison with heathy control subjects. Psychiatry Res. 56:1995;81-95.
74. Mendelson J.H., Stein S. Serum cortisol levels in alcoholic and non-alcoholic subjects during experimentally induced ethanol intoxication. Psychosom Med. 28:1966;616-626.
75. Risher-Flowers D., Adinoff B., Ravitz B., Bone G.H., Martin P.R., Nutt D., Linnoila M. Circadian rythms of cortisol during alcohol withdrawal. Adv Alcohol Subst Abuse. 7:1988;37-41.
76. Keedwell P.A., Poon L., Papadopoulos A.S., Marshall E.J., Checkley S.A. Salivary cortisol measurements during a medically assisted alcohol withdrawal. Addict Biol. 6:2001;247-257.
77. Hundt W., Zimmermann U., Pottig M., Spring K., Holsboer F. The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal. Alcohol Clin Exp Res. 25:2001;687-691.
78. Von Bardeleben U., Heuser I., Holsboer F. Human CRH stimulation response during acute withdrawal and after medium-term abstention form alcohol abuse. Psychoneuroendocrinology. 14:1989;441-449.
79. Eisenhofer G., Whiteside E.A., Johnson R.H. Plasma catecholamine responses to change of posture in alcoholics during withdrawal and after continued abstinence from alcohol. Clin Sci. 68:1985;71-78.
80. Linnoila M., Mefford I., Nutt D., Adinoff B. NIH conference: Alcohol withdrawal and noradrenergic function. Ann Intern Med. 107:1987;875-889.
81. Smith A.J., Brent P.J., Henry D.A., Foy A. Plasma noradrenaline, platelet alpha 2-adrenoceptors and functional scores during ethanol withdrawal. Alcohol Clin Exp Res. 14:1990;497-502.
82. Hawley R.J., Major L.F., Schulman E.A., Lake C.R. CSF levels of norepinephrine during alcohol withdrawal. Arch Neurol. 38:1981;289-292.
83. Hawley R.J., Nemeroff C.B., Bissette G., Guidotti A., Rawlings R., Linnoila M. Neurochemical correlates of sympathetic activation during severe alcohol withdrawal. Alcohol Clin Exp Res. 18:1994;1312-1316.
84. Borg S., Czarnecka A., Kvande H., Mossberg D., Sedvall G. Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal. Alcohol Clin Exp Res. 7:1983;411-415.
85. Sorg B.A., Kalivas P.W. Effects of cocaine and footshock stress on extracellular dopamine levels in the ventral striatum. Brain Res. 559:1991;29-36.
86. Hamamura T., Ichimaru Y., Fibiger H.C. Amphetamine sensitization enhances regional c-fos expression produced by conditioned fear. Neuroscience. 76:1997;1097-1103.
87. Diaz-Otanez C.S., Del Rosario Capriles N., Cancela L.M. D1 and D2 dopamine and opiate receptors are involved in restraint stress-induced sensitization to the psychostimulant effects of amphetamine. Pharmacol Biochem Behav. 58:1997;9-14.
88. Cador M., Cole B.J., Koob G.F., Stinus L., Le Moal M. Central administration of corticotropin-releasing factor induces long-term sensitization to D-amphetamine. Brain Res. 606:1993;181-186.
89. Stam R., Bruijnzeel A.W., Wiegant V.M. Long-lasting stress sensitisation. Eur J Pharmacol. 405:2000;217-224.
90. Ramsey N.F., Van Ree J.M. Emotional but not physical stress enhances intravenous cocaine self-administration in drug-naive rats. Brain Res. 608:(2):1993;216-222.
91. Kuzmin A., Semenova S., Zvartea E.E., Van Ree J.M. Enhancement of morphine self-administration in drug naive inbred strains of mice by acute emotional stress. Eur Neuropsychopharm. 6:1996;63-68.
92. Haney M., Maccari S., Le Moal M., Simon H., Piazza P.V. Social stress increases the acquisition of cocaine self-administration in male and female rats. Brain Res. 698:1995;46-52.
93. Tidey J.W., Miczek K.A. Acquisition of cocaine self-administration after social stress: role of accumbens dopamine. Psychopharmacology. 130:(3):1997;203-212.
94. Ballenger J.C., Post R.M. Kindling as a model for alcohol withdrawal syndromes. Br J Psychiat. 133:1978;1-14.
95. Booth B.M., Blow F.C. The kindling hypothesis; further evidence from a US National Study on alcoholic men. Alcohol Alcohol. 28:1993;593-598.
96. Worner T.M. Relative kindling effect of readmissions in alcoholics. Alcohol Alcohol. 31:1996;375-380.
97. Clemmesen L., Hemmingsen R. Physical dependence on ethanol during multiple intoxication and withdrawal episodes in the rat: evidence of a potentiation. Acta Pharmacol Tox. 55:1984;345-350.
98. Becker H.C., Hale R.L. Repeated episodes of ethanol wtihdrawal potentiate the severity of subsequent withdrawal seizures: an animal model of alcohol withdrawal 'kindling'. Alcohol Clin Exp Res. 17:1993;94-98.
99. Becker H.C., Diaz-Granadoz J.L., Hale R.L. Exacerbation of ethanol withdrawal seizures in mice with a history of multiple withdrawal experience. Pharmacol Biochem Behav. 57:1997;179-183.
100. Ulrichsen J., Clemmesen L., Hemmingsen R. Convulsive behaviour during alcohol dependence: discrimination between the role of intoxication and withdrawal. Psychopharmacology. 107:1992;97-102.
101. Ulrichsen J., Bech B., Allerup P., Hemmingsen R. Diazepam prevents progression of kindled alcohol withdrawal behaviour. Psychopharmacology. 121:1995;451-460.
102. Mhatre M.C., McKenzie S.E., Gonzalez L.P. Diazepam during prior ethanol withdrawals does not alter seizure susceptibility during a subsequent withdrawal. Pharmacol Biochem Behav. 68:2001;339-346.
103. Lovinger D.M. Excitotoxicity and alcohol-related brain damage. Alcohol Clin Exp Res. 17:1993;19-27.
104. Tsai G., Gastfriend D.R., Coyle J.T. The glutamatergic basis of human alcoholism. Am J Psychiat. 152:1995;332-340.
105. Kril J.J., Halliday G.M., Svoboda M.D., Cartwright H. The cerebral cortex is damaged in chronic alcoholics. Neuroscience. 79:1997;983-998.
106. Schweinburg B.C., Taylor M.J., Alhassoon O.M., Videen J.S., Brown-Patterson T.L., Berger F., Grant I. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1h magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury. Alcohol Clin Exp Res. 25:2001;924-934.
107. 99mTc-bicisate SPECT in alcohol-dependent patients. Alcohol Alcohol. 36:2001;556-563.
108. Noël X., Van der Linden M., Sferrazza R., Schmidt N., De Mol J., Hanak C., Pelc I., Verbanck P. Supervisory attentional system in recently detoxified alcoholic patients. Arch Gen Psychiat. 58:2001;1152-1158.
109. Cadete-Leite A., Tavares M.A., Uylings H.B., Paula-Barbosa M. Granule cell loss and dendritic regrowth in the hippocampal dentate gyrus of the rat after chronic alcohol consumption. Brain Res. 473:1988;1-14.
110. Walker D.W., Barnes D.E., Zornetzer S.F., Hunter B.E., Kubanis P. Neuronal loss in hippocampus induced by prolonged ethanol consumption in rats. Science. 209:1980;711-713.
111. Lundqvist C., Alling C., Knoth R., Volk B. Intermittent ethanol exposure of adults rats: hippocampal cell loss after one month of treatment. Alcohol Alcohol. 30:1995;737-748.
112. Lundqvist C., Volk B., Knoth R., Alling C. Long-term effects of intermittent versus continuous ethanol exposure on hippocampal synapses of the rat. Acta Neuropathol. 87:1994;242-249.
113. Franke H., Kittner H., Berger P., Wikner K., Schramek J. The reaction of astrocytes and neurons in the hippocampus of adult rats during chronic ethanol treatment and correlations to behavioral impairments. Alcohol. 14:1997;445-454.
114. Davidson M.D., Wilce P., Shanley B.C. Increased sensitivity of the hippocampus in ethanol-dependent rats to toxic effect of N-methyl-D-aspartatic acid in vivo. Brain Res. 606:1993;5-9.
115. Sepulveda C., Bustos G., Gysling K., Seguel M., Labarca R. Effect of in vitro ethanol and chronic ethanol consumption on the release of excitatory amino acids in the rat hippocampus. Brain Res. 674:1995;104-106.
116. Elliot E.M., Sapolsky R.M. Corticosterone enhances kainic acid-induced calcium elevation in cultured hippocampal neurons. J Neurochem. 59:1992;1033-1040.
117. Elliot E.M., Sapolsky R.M. Corticosterone impairs hippocampal neuronal calcium regulation. Possible mediating mechanisms. Brain Res. 602:1993;84-90.
118. McIntosh L.J., Sapolsky R.M. Glucocorticoids may enhance oxygen radical-mediated neurotoxicity. Neurotoxicology. 17:1996;873-882.
119. Uno H., Eisele S., Sakai A., Shelton S., Baker E., DeJesus O., Holden J. Neurotoxicity of glucocorticoids in the primate brain. Horm Behav. 28:1994;336-348.
120. Yusim A., Franklin L., Brooke S., Ajilore O., Sapolsky R. Glucocorticoids exacerbate the deleterious effects of gp120 in hippocampal and cortical explants. J Neurochem. 74:2000;1000-1007.
121. Koob G.F., Mason B.J., De Witte P., Littleton J., Siggins G.R. Potential neuroprotective effects of acamprosate. Alcohol Clin Exp Res. 26:2002;586-592.